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wall. Only one patient developed third degree AV block which
required temporary pacing.
Conclusion: Early intervention if neccessarywhen the patient is in
sinus rhythm. Adequate rate control by pharmacological means
before subjecting the pts to PTMC. Optimizing the dose of digoxin
so that it neither causes brady arrhythmia, at the same time
preventing tachyarrhythmias. Every effort to bemade to avoid low
puncture, balloon slippage and inadvertent manipulation of
guidewires and catheters. One must be ready to do pacing if
warrented. Meticulous pre procedural evaluation, patient prepa-
ration and careful handling of hardwares will prevent arrhythmia
related complications.
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Background: After Percutaneous transvenous mitral commissur-
otomy (PTMC), symptomatic mitral valve restenosis develops in 4
to 39 % cases. The current study aims to identify demographic,
clinical characteristics, echocardiographic parameters that may
predict the successful result of redo PTMC in post-PTMC symp-
tomatic mitral restenosis.
Methods: Single centre retrospective observational study of in
hospital patients in last 5 years Successful PTMC was defined as
MVA> 1.5 cm2 without a postprocedural MR grade>2 using 2D
Echocardiography.
Results: There were 324 patients (230 females, 94 males); mean
age 33 (12 to 59 years). Median time interval from the initial pro-
cedure was 8.3 yrs (0.6 to 19 yrs).261 (80%) were in NYHA class II.
271(84%) were in sinus rhythm and 53(16%) in atrial fibrillation.
Successful PTMC was seen in 251(77.5 %) patients. Mean Wilkin
score was 9.9. There was a significant increase in the mean MVA
from 1.0 to 1.6 cm2, mean.RVSP decreased significantly from 52 to
36 mm Hg. Four patients developed severe MR and three under-
went emergency MVR. 6 patients developed cardiac tamponade
requiring pericardiocentesis and one had femoral artery throm-
bosis treated conservatively. There were no in-hospital deaths or
systemic embolisation. Unsuccessful PTMC was seen in 73(22.5%)
patients. These unsuccessful results were due to post procedure
MR grade >2 in 4 patients (1.2%) and suboptimal secondary MVA
<1.5 cm2 in 69 patients (21.3%). Predictors of poor outcome were-
Right ventricular dysfunction in 16, severe tricuspid regurgitation
in 10,Wilkin scores with severe subvalvular fusion in 63 &high
calcium score in 20 patients.
Conclusion: Redo PTMC in patients with mitral restenosis is
feasible safe procedure with good success rate and optimal results
with acceptable morbidity. In patients with low echo scores and
no comorbid diseases, repeat PTMC should be the procedure of
choice. For patients with more extensive valvular and subvalvular
deformity, redo PTMC can be used as a palliative technique in
these patients when they are at high risk of morbidity and mor-
tality with MVR due to the presence of associated significant co-
morbid diseases.
NT pro BNP as a potential marker of left atrial
dysfunction in rheumatic mitral stenosis and its
correlation with improvement in left atrial
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volvotomy (PBMV) with intermediate term follow
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Background: Rheumatic heart disease is a common problem in
developing countries. Plasma BNPlevels are affected in rheumatic
heart disease, and can be correlated with disease severity.
Aims: To correlate levels of NT pro BNP with echocardiographic
(including LA strain and strain rate (S/Sr) and hemodynamic pa-
rameters of LA functions and with improvement with PBMV with
intermediate term follow up of 1 year.
Methods: 48 patients of severe MS undergoing PBMV were
enrolled. All subjects underwent detailed history, physical ex-
amination. All the tests were done within 12 hours prior to PBMV
and repeated 12 hours post PBMV, at 1 month and at 1 year.
Transthoracic echo was performed using Vivid 7 echocardio-
graphic unit (GE) Tissue Doppler Echocardiography derived S/Sr
imaging were used for assessment of LA regional longitudinal
function using apical 2- and 4-chamber views. Peak S/Sr were
measured at each mid-LA segment (septal, lateral, anterior, and
inferior) during ventricular systole (LAs) and at early (LAe) and late
diastole (LAa). LAA contraction velocity was calculated using trans
esophageal echocardiography and correlated with NT pro BNP
levels. Invasively, cardiac output was calculated using Swan-Ganz
Standard Thermodilution Pulmonary Artery Catheter and Vigi-
lance II moniter. PCWP, pulmonary artery pressure and other cath
data were correlated with NT pro BNP levels pre and post PBMV.
Results: Mean PrePBMV NTproBNP was 700 pg/ml. Mean level 1
day post PBMV was 425pg/ml, and after 1 month 300pg/ml(p<.05).
At 1 year the levels of NTproBNPwere 50pgm/ml. S/Sr at eachmid-
LA segment (septal, lateral, anterior, and inferior) during ven-
tricular systole (LAs), at early (LAe) and late diastole (LAa) were
significantly lower in the patients than in the controls (P < 0.0001)..
S/Sr values improved significantly (p < 0.05) in most segments at
day 1 and at post PTMC 1 month. At 1 year these values showed
more than 50% increase that was related significantly with NT pro
BNP levels. , Also fall in mean pulmonary artery pressure, fall in
PCWP and rise in cardiac output, all correlated significantly with
NT pro BNP levels.
Conclusion: NT pro BNP levels correlate significantly with LA
dysfunction and predict improvement in LA function post PBMV
in Rheumatic mitral stenosis even at 1 year.
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Background: Mitral regurgitation (MR) causes progressive systolic
and diastolic LV dysfunction and has negative impacts on the
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prognosis of patients withMR. Accurate assessment of ventricular
function and severity of MR using echocardiography alonemay be
difficult and bring us to diagnostic dead end. The use of echo-
cardiographic indices and biomarkers in combination can provide
an accurate assessment of MR severity and LV dysfunction. The
aim of this study is to assess correlation of NT Pro BNP levels with
echocardiographic indices in patients with MR.
Methods: The study population consisted of 50 patients diagnosed
to have MR. Transthoracic, M mode,2-Dimensional and Doppler
echocardiography performed using a Philips iE-33 machine. NT
pro BNP levels were measured by using Roche CARDIAC Pro BNP
test kit, Roche diagnostics limited, Germany and Cobas H 232 POC
system.
Results: BNP levels in groups with mild, moderate and severe MR
were 60 ± 6, 76±7.5, 78±6.6 pg/ml respectively (p¼0.162). Myocar-
dial performance index were 0.44±0.24, 0.42±0.23 & 0.53±0.28 in
patients with mild, moderate and severe MR respectively. But
there were no significant difference among three groups
(p¼0.404). BNP plasma levels were increased with symptoms in
patients with MR (NYHA I:60 ±5,NYHA II:102±6.5, NYHA
III:160±9pg/ml, p<0.001). BNP plasma levels were significantly
correlated with MPI (p¼0.004) and following echocardiographic
indices, LVEDV (p<0.001), LVESV p<0.001), LVEDD (p<0.001),
LVESD (p<0.001), LA dimension (p¼0.004) and negative correlation
with LV ejection fraction ( p<0.001),but there were no significant
correlations between BNP plasma level and MR volume (p¼0.33),
MR Vena contracta width (P¼0.23), MR Effective Regurgitant
Orifice Area (P¼0.34) and LA volume (p¼0.6)).
Conclusion: This study showed that BNP measurement has the
same sensitivity and specificity as echocardiographic indices and
may be used as a biomarker for the evaluation of patients with MR
in combination with echo indices.
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Background: Tricuspid valve disease frequently accompanies
rheumatic mitral valve disease.Organic tricuspid valve disease
with concomitant TS and TR is also frequent, and uncorrected
severe TR has been associated with adverse outcomes of both
BMV and surgical mitral valve reconstruction/replacement.
Methods: We retrospectively analysed patients in our hospital
who serially underwent concomitant balloon dilation of tricuspid
valve along with BMV and sought to determine predictors of
concomitant tricuspid valve disease requiring tricuspid valve
intervention, and clinical characteristics of patients undergoing
the same.Of the 12005 patients who underwent BMV at our
institute,10916 (91%) had some affection of tricuspid valve ,with
4716 (38.3%)found to have at least moderate TR or more.26 pa-
tients (0.21%)have undergone simultaneous TVBD, with 3 patients
having undergone the procedures twice. The decision to perform
TVBD during BMVwasmade according to trans-tricuspid gradient
measured as continuous wave signal across the “doming
“tricuspid valve , and difference of RVedp and RA mean pressures
by post BMV cath.The same Accura balloon that was used for BMV
was used for the TVBD( sizes 24,26,28) by withdrawing it across
the tricuspid valve.The balloon was dilated under fluoro guidance
till the waist of the stenosis across TV disappeared. Between serial
dilations, echo guidance was taken to assess result of previous
dilation.
Results: Patients undergoing BMV who underwent concomitant
tricuspid balloon dilation( Group A) for rheumatic TS were more
likely to be female (n¼21 of 26 patients( p< 0.001)),older(mean age:
30.5+/- 4.5 years ), more likely to present with right-sided symp-
toms , more likely have undergone a past valve procedure( either
BMV/CMV,n¼12) and have longer duration of disease( mean
duration: 11.4 +/-4.4 years,p< 0.001) than Group B patients.14 pa-
tients of the 26 ( group A) had AF (p<0.001) and were on oral
anticoagulation. Concomitant mitral involvement was seen 100%
patients, andmoderately advanced aortic valve disease (moderate
AR, mild to moderate AS) also was significantly more in group A
patients.
Pre-BMV trans-mitral gradients (due to the upstream TS,
however were not statistically significantly different between
groups A and B. The post procedural outcomes of the BMV with
TVBD in group A also did not reach significantly different values
as compared to those who underwent BMV alone. Though a
satisfactory initial result of TVBD was obtained in all patients,
most patients were referred for combined surgery in future
due to advanced disease with mitral, aortic and tricuspid
involvement.
Conclusions: Concomitant tricuspid involvement can be consid-
ered a frequent accompaniment of advanced rheumatic mitral
disease, and concomitant TVBD during BMV can be safe and
efficacious procedure with good immediate benefits but needing
mitral and tricuspid valve surgery in future. Higher patient age,
presence of AF and concomitant aortic disease probably are
pointers towards advanced age of disease in these patients.
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Background: Rheumatic fever and rheumatic heart disease
continue to be the major health problem in all developing coun-
tries including Bangladesh. Percutaneous Transvenous mitral
Commissurotomy (PTMC) is an established non-surgical modality
for the treatment of severe rheumatic mitral valve stenosis.The
purpose of this study was to evaluate our immediate and in-
hospital results of Percutaneous Transvenous Mitral Commis-
surotomy (PTMC) in patients with restenosis with previous mitral
surgery(CMC).
Methods: The study group included 880 consecutive patients who
underwent PTMC at the National Institute of cardiovascular Dis-
eases (NICVD), Dhaka and Al eHelal Heart Institute, Mirpur, Euro-
Bangla Heart Hospital, Lalmatia, Dhaka between May 2003 and
December 2012. Safety, efficacy and in-hospital results of percu-
taneous transvenous mitral commissurotomy were analyzed in
800 patients underwent PTMC without previous CMC (group 1)
and compared with 60 those of with previous CMC (group 2).
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